Basic Information
LncRNA/CircRNA Name | HOXC-AS1 |
Synonyms | NA |
Region | GRCh38_12:53999022-54000010 |
Ensemble | ENSG00000250451 |
Refseq | NR_047504 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | gastric cancer |
ICD-0-3 | C16 |
Methods | qPCR etc. |
Sample | gastric cancer tissues,cell line (HFE145,AGS, MKN45, MKN28,HGC-27) |
Expression Pattern | up-regulated |
Function Description | lncRNA HOXC-AS1 expression is upregulated in GC cells, decrease of lncRNA HOXC-AS1 inhibited cell viability. The binding was validated by RNA pull-down. Additionally, inhibition of eIF4AIII induced increase of lncRNA HOXC-AS1, thus promoting the cell proliferation and EMT process but deterring apoptosis of gastric cancer cells. Wnt/?-catenin signaling was impeded by HOXC-AS1 inhibition but restored by suppressed eIF4AIII. |
Pubmed ID | 32307743 |
Year | 2020 |
Title | lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/?-Catenin signaling. |
External Links
Links for HOXC-AS1 | GenBank HGNC NONCODE |
Links for gastric cancer | OMIM COSMIC |